Capsiate treatment in liver surgeries may compromise its recovery

Acta Cir Bras. 2018 May;33(5):439-445. doi: 10.1590/s0102-865020180050000006.

Abstract

Purpose: To investigate the effects of capsiate treatment on hepatic hyperplasia in partially hepatectomized rats.

Methods: The animals were divided into a Capsiate group (CPH), a Capsiate Post-Partial Hepatectomy group (CPPH) and a Partial Hepatectomy Control group (PH). CPH and CPPH animals received 60 mg/kg/day Capsiate for 30 days. Next, the rats underwent partial hepatectomy. CPPH animals continued to receive treatment for 48 h after partial hepatectomy. Liver tissue and intracardiac blood samples were obtained 24 or 48 h after PH.

Results: Capsiate treatment interfered with hepatic parameters, reducing the number of mitoses and apoptosis and increasing blood ALT and alkaline phosphatase concentrations.

Conclusion: Capsiate treatment preceding hepatic surgery may compromise the initial period of postoperative recovery.

MeSH terms

  • Alanine Transaminase / metabolism
  • Alkaline Phosphatase / metabolism
  • Animals
  • Apoptosis / drug effects
  • Aspartate Aminotransferases / metabolism
  • Capsaicin / analogs & derivatives*
  • Capsaicin / pharmacology
  • Hepatectomy*
  • Liver / drug effects
  • Liver / enzymology*
  • Liver / pathology
  • Liver Regeneration / drug effects
  • Male
  • Mitosis / drug effects
  • Rats
  • Rats, Wistar

Substances

  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Alkaline Phosphatase
  • capsiate
  • Capsaicin